Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026)
Sarepta Therapeutics (SRPT) recorded quarterly Prepaid Assets of $2.2 million in Q1 2026, down 44.63% quarter-over-quarter from $4.0 million in Q4 2025, and down 97.9% on a YoY basis from $105.5 million in Q1 2025.
Sarepta Therapeutics (SRPT) Prepaid Assets (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 97.9% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 97.9% YoY), while the FY2025 annual figure was $4.0 million, down 95.57% from the prior year.
- Prepaid Assets was $2.2 million for Q1 2026 at Sarepta Therapeutics, down from $4.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $179.8 million in Q1 2023 to a low of $1.2 million in Q3 2022.
- Historically, Prepaid Assets has averaged $41.1 million across 5 years, with a median of $3.4 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets sank 99.17% in 2022, then jumped 5303.59% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $149.9 million in 2022, then sank by 97.76% to $3.4 million in 2023, then soared by 2598.72% to $90.5 million in 2024, then slumped by 95.57% to $4.0 million in 2025, then plunged by 44.63% to $2.2 million in 2026.
- The last three Prepaid Assets figures came in at $2.2 million (Q1 2026), $4.0 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 4.11 Mn |
| Mar 31, 2025 | 105.48 Mn |
| Dec 31, 2024 | 90.46 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.93 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 3.35 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 179.77 Mn |
| Dec 31, 2022 | 149.89 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 3.28 Mn |
| Mar 31, 2022 | 140.33 Mn |
| Dec 31, 2021 | 149.03 Mn |
| Sep 30, 2021 | 147.94 Mn |
| Jun 30, 2021 | 141.67 Mn |